LUCA Science
PrivateLast Round
Series B
Jun 6, 2022
Total Funding Raised
$40.1M
Company Overview
LUCA Science is a biotechnology company that develops functional mitochondria as therapeutic agents to treat damaged tissues and organs by enhancing and stabilizing mitochondrial activity.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology
Business Model
B2B
Customer Profile
Government Contracts, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
LUCA Science Comps
Public and private peers based on sector, stage, and business model.
LUCA Science Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Jun 6, 2022 | ||||
| Series A | Sep 1, 2020 |
Key People
Founding team and executive leadership
LUCA Science Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Daiwa Securities Group | Series B |
| Shinsei Capital Partners | Series B |
| DCI Partners | Series B |
| 日本ベンチャーキャピタル株式会社 | Series B, Series A |
| Remiges Ventures | Series B, Series A |
| 4Bio Capital | Series B |
| Nissay Capital | Series B |
LUCA Science Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about LUCA Science's valuation, stock price, and market status.
